Vivek Ramaswamy

CIK 1635075 · Principal Executive Officer · last filed 2025-12-15

Vivek Ramaswamy is a Principal Executive Officer who has filed 33 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for ROIV, was dated Dec 15, 2025. Across all open-market trades the lifetime net is −$223.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.91B across reported positions. 36 SEC filings were submitted jointly with Roivant Sciences Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.91B

Companies

Total Filings

Lifetime Open-Market Net

-$223.71M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

C/O STEVE ROBERTS
853 NEW JERSEY AVE., SE STE. 200-231
WASHINGTON, DC 20003

Related Filers

Roivant Sciences Ltd. — 36 joint filings, latest 2026-05-06

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ROIV	10%+ Owner	47,011,612	$35.95	$1.69B	-$193.16M	10	2025-12-15
ASST	10%+ Owner	7,112,837	$30.82	$219.22M	$1.25M	2	2025-11-07
Roivant Sciences Ltd. (ROIVW) Delisted	Director	54,730,523	$2.75	$150.51M	-$31.80M	4	2023-08-29
ABUS	Director	—	$4.44	—	$0	4	2018-06-22

Recent Filings

33 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2025-12-15	ROIV	Mixed	−1	-$67.92M	EDGAR
2025-11-17	ROIV	Sell (S)	−1,854,603	-$37.94M	EDGAR
2025-11-07	ASST	Buy (P)	+15,625	$1.25M	EDGAR
2025-09-16	ASST	—	—	$0	EDGAR
2025-09-05	ROIV	Sell (S)	−1,775,749	-$22.46M	EDGAR
2025-06-23	ROIV	Sell (S)	−1,142,273	-$13.08M	EDGAR
2025-06-20	ROIV	Notice (144)	−577,007	-$6.61M	EDGAR
2025-06-18	ROIV	Notice (144)	−565,266	-$6.47M	EDGAR
2025-06-06	ROIV	Sell (S)	−748,230	-$8.45M	EDGAR
2025-06-06	ROIV	Notice (144)	−200,800	-$2.25M	EDGAR

Showing 1–10 of 33

Page 1 of 4 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.